• image 01
    Volume 1, No.1, 2012
  • image 02
    Volume 1, No.2, 2012
  • image 01
    Volume 1, No.3, 2012
  • image 02
    Volume 2, No.1, 2013
  • image 02
    Volume 2, No.2, 2013
  • image 02
    Volume 2, No.S1, 2013
  • image 02
    Volume 2, No.3, 2013
  • image 02
    Volume 2, No.4, 2013
  • image 02
    Volume 3, No.1, 2014
  • image 02
    Volume 3, No.2, 2014
  • Volume 3, No3
    Volume 3, No.3, 2014
  • Volume 3, No4
    Volume 3, No.4, 2014
  • Volume 4, No1
    Volume 4, No.1, 2015
  • Volume 4, No2
    Volume 4, No.2, 2015
  • Volume 4, No3
    Volume 4, No.3, 2015
  • Volume 4, No4
    Volume 4, No.4, 2015
  • Volume 5, No1
    Volume 5, No.1, 2016
  • image 01
  • image 02
  • Login|Register
  • Chem Sci Trans., 2017, 6(1),  pp 27-34  

    DOI:10.7598/cst2017.1302

    Research Article

    An Improved Synthesis of (S)-5-chloro-N-{[2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]oxazolidin-5-yl]methyl} thiophene-2-carboxamide

  • SRIDHAR PRASANGI*, SRINIVAS REDDY DESIREDDY, VELIVELA SRINIVSASA RAO, Y. L. N. MURTHY and MAHESH PALLA
  • Department of PNCO, Andhra University, Visakhapatnam-530003, India
    Optimus drugs Ltd., Hyderabad
  • Abstract

    A new and improved process has been developed for the oral anticoagulant rivaroxaban with 99.9% purity and 57.7% overall yield (three main steps). Formation and control of four observed impurities is described

    Keywords

    Anticoagulant, Rivaroxaban, Synthesis, Impurity

    This article has been viwed 257 times

      

    Citations for this article 0

      

    No Citations